JPH10512759A - 酵素触媒作用アシル化による1級及び2級のヘテロ原子置換アミンのラセミ体分割 - Google Patents
酵素触媒作用アシル化による1級及び2級のヘテロ原子置換アミンのラセミ体分割Info
- Publication number
- JPH10512759A JPH10512759A JP8523205A JP52320596A JPH10512759A JP H10512759 A JPH10512759 A JP H10512759A JP 8523205 A JP8523205 A JP 8523205A JP 52320596 A JP52320596 A JP 52320596A JP H10512759 A JPH10512759 A JP H10512759A
- Authority
- JP
- Japan
- Prior art keywords
- heteroatom
- amino
- substituted
- ester
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001412 amines Chemical class 0.000 title claims abstract description 86
- 230000010933 acylation Effects 0.000 title abstract description 6
- 238000005917 acylation reaction Methods 0.000 title abstract description 6
- 150000002148 esters Chemical class 0.000 claims abstract description 27
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 12
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 claims abstract description 12
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000001408 amides Chemical class 0.000 claims abstract description 10
- 125000004434 sulfur atom Chemical group 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 8
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- -1 neighbor- Chemical compound 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 39
- 239000004367 Lipase Substances 0.000 claims description 18
- 108090001060 Lipase Proteins 0.000 claims description 17
- 102000004882 Lipase Human genes 0.000 claims description 17
- 235000019421 lipase Nutrition 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 14
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 102000004157 Hydrolases Human genes 0.000 claims description 9
- 108090000604 Hydrolases Proteins 0.000 claims description 9
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 claims description 8
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 7
- JFFOUICIRBXFRC-RFZPGFLSSA-N (1r,2r)-2-aminocyclopentan-1-ol Chemical compound N[C@@H]1CCC[C@H]1O JFFOUICIRBXFRC-RFZPGFLSSA-N 0.000 claims description 6
- JBULSURVMXPBNA-RXMQYKEDSA-N (2s)-2-amino-3,3-dimethylbutan-1-ol Chemical compound CC(C)(C)[C@H](N)CO JBULSURVMXPBNA-RXMQYKEDSA-N 0.000 claims description 6
- JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 claims description 6
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims description 6
- ZDPVRXUQQGZTEY-SECBINFHSA-N [(2R)-2-phenyloxiran-2-yl]methanol Chemical compound C=1C=CC=CC=1[C@@]1(CO)CO1 ZDPVRXUQQGZTEY-SECBINFHSA-N 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 claims description 6
- 229960002179 ephedrine Drugs 0.000 claims description 6
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 claims description 6
- 229960003908 pseudoephedrine Drugs 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- LOPKSXMQWBYUOI-RKDXNWHRSA-N (1r,2r)-1-amino-2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2[C@@H](N)[C@H](O)CC2=C1 LOPKSXMQWBYUOI-RKDXNWHRSA-N 0.000 claims description 5
- JFFOUICIRBXFRC-CRCLSJGQSA-N (1r,2s)-2-aminocyclopentan-1-ol Chemical compound N[C@H]1CCC[C@H]1O JFFOUICIRBXFRC-CRCLSJGQSA-N 0.000 claims description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 229960000395 phenylpropanolamine Drugs 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- QYYAFOFOLYOYID-UHFFFAOYSA-N 1,2-dianilinoethanol Chemical compound C=1C=CC=CC=1NC(O)CNC1=CC=CC=C1 QYYAFOFOLYOYID-UHFFFAOYSA-N 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 230000002906 microbiologic effect Effects 0.000 claims description 4
- ZXXPQUTYJUIYGA-UHFFFAOYSA-N 2-(3-amino-2-hydroxyphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=CC(N)=C1O ZXXPQUTYJUIYGA-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 229960003609 cathine Drugs 0.000 claims description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims description 3
- CMQZETQFZHIYJG-UHFFFAOYSA-N 2-(n-phenylanilino)ethanol Chemical compound C=1C=CC=CC=1N(CCO)C1=CC=CC=C1 CMQZETQFZHIYJG-UHFFFAOYSA-N 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- RMIODHQZRUFFFF-UHFFFAOYSA-N methoxyacetic acid Chemical compound COCC(O)=O RMIODHQZRUFFFF-UHFFFAOYSA-N 0.000 claims description 2
- KMGCKSAIIHOKCX-UHFFFAOYSA-N 2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2CC(O)CC2=C1 KMGCKSAIIHOKCX-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- SJWUULVPYAMRCJ-UHFFFAOYSA-N [N].[O].[P] Chemical compound [N].[O].[P] SJWUULVPYAMRCJ-UHFFFAOYSA-N 0.000 claims 1
- 239000000539 dimer Substances 0.000 claims 1
- 125000004185 ester group Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 125000005842 heteroatom Chemical group 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PQMCFTMVQORYJC-PHDIDXHHSA-N (1r,2r)-2-aminocyclohexan-1-ol Chemical compound N[C@@H]1CCCC[C@H]1O PQMCFTMVQORYJC-PHDIDXHHSA-N 0.000 description 3
- PQMCFTMVQORYJC-NTSWFWBYSA-N (1r,2s)-2-aminocyclohexan-1-ol Chemical compound N[C@H]1CCCC[C@H]1O PQMCFTMVQORYJC-NTSWFWBYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- JLEKJZUYWFJPMB-UHFFFAOYSA-N ethyl 2-methoxyacetate Chemical compound CCOC(=O)COC JLEKJZUYWFJPMB-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010084311 Novozyme 435 Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 229910052736 halogen Chemical group 0.000 description 2
- 150000002367 halogens Chemical group 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- XYXFJNIUUWEUIJ-UHFFFAOYSA-N propan-2-yl 2-methoxyacetate Chemical compound COCC(=O)OC(C)C XYXFJNIUUWEUIJ-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- JIMSXLUBRRQALI-VXGBXAGGSA-N (1r,2r)-2-phenylmethoxycyclopentan-1-amine Chemical compound N[C@@H]1CCC[C@H]1OCC1=CC=CC=C1 JIMSXLUBRRQALI-VXGBXAGGSA-N 0.000 description 1
- MTEZLAATISORQK-UHFFFAOYSA-N 2-methoxyacetamide Chemical compound COCC(N)=O MTEZLAATISORQK-UHFFFAOYSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- AFCIMSXHQSIHQW-UHFFFAOYSA-N [O].[P] Chemical compound [O].[P] AFCIMSXHQSIHQW-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000003975 aryl alkyl amines Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000006250 specific catalysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/007—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving acyl derivatives of racemic amines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.プロテアーゼ又はリパーゼの存在下に、ヘテロ原子置換アミンとエステルと を反応させることにより、化合物2−アミノ−1−ブタノール、エフェドリン、 プソイドエフェドリン、ノルエフェドリン、ノルプソイドエフェドリン、t−ロ イシノール、フェニルグリシドール、1,2−ジフェニルアミノエタノール、シ ス−及びトランス−2−アミノ−シクロペンタノール、シス−及びトランス−1 −アミノ−2−ヒドロキシインダン、シス−及びトランス−アミノシクロヘキサ ノール、スタチン、2−ヒドロキシ−3−アミノ−フェニルプロピオン酸を除い たアシル化された1級及び2級のヘテロ原子置換アミンを製造する場合に、この エステルの酸成分はカルボニル炭素に対してα−位の炭素原子に結合している1 個のフッ素−、窒素−、燐−、酸素−又は硫黄原子を有することを特徴とする、 アシル化された1級及び2級のヘテロ原子置換アミンの製法。 2.ヒドロラーゼの存在下でのエステルとの反応及び引き続くエナンチオ選択的 にアシル化されたヘテロ原子置換されたアミンを反応されなかったヘテロ原子置 換アミンの他のエナンチオマーから分離することにより、化合物2−アミノ−1 −ブタノール、エフェドリン、プソイドエフェドリン、ノルエフェド リン、ノルプソイドエフェドリン、t−ロイシノール、フェニルグリシドール、 1,2−ジフェニルアミノエタノール、シス−及びトランス−2−アミノ−シク ロペンタノール、シス−及びトランス−1−アミノ−2−ヒドロキシインダン、 シス−及びトランス−アミノシクロヘキサノール、スタチン、2−ヒドロキシ− 3−アミノ−フェニルプロピオン酸を除いた1級及び2級のヘテロ原子置換アミ ンをラセミ体分割する方法において、この際、このエステルの酸成分は、カルボ ニル炭素原子に対してα−位の炭素原子に結合している1個のフッ素−、窒素− 、燐−、酸素−又は硫黄原子を有することを特徴とする、1級及び2級のヘテロ 原子置換アミンのラセミ体分割法。 3.化合物2−アミノ−1−ブタノール、エフェドリン、プソイドエフェドリン 、ノルエフェドリン、ノルプソイドエフェドリン、t−ロイシノール、フェニル グリシドール、1,2−ジフェニルアミノエタノール、シス−及びトランス−2 −アミノ−シクロペンタノール、シス−及びトランス−1−アミノ−2−ヒドロ キシインダン、シス−及びトランス−アミノシクロヘキサノール、スタチン、2 −ヒドロキシ−3−アミノ−フェニルプロピオン酸を除いた光学活性の1級及び 2級のヘテロ原子置換アミンを製造する方法において、 a)ラセミ性のヘテロ原子置換アミンを、プロテアーゼ又はリパーゼの存在下 に、その酸成分がカルボニル炭素原子に対してα−位の炭素原子に結合している 1個のフッ素−、窒素−、隣−、酸素−又は硫黄原子を有するエステルを用いて 、エナンチオ選択的にアシル化し、 b)光学的活性のヘテロ原子置換アミンと光学的活性のアシル化されたヘテロ 原子置換アミンとの混合物を分離して、ヘテロ原子置換アミンの1個のエナンチ オマーを得、 c)所望の場合には、アシル化されたヘテロ原子置換アミンからこのアミンの 他のエナンチオマーをアミド分割により取得する ことを特徴とする、光学的活性の1級及び2級のヘテロ原子置換アミンを製造 する方法。 4.工程b)及びc)に引き続き、もう一つの工程で、不所望のエナンチオマー をラセミ化し、引き続きラセミ分割の方法に戻すことを特徴とする、請求項3に 記載の方法。 5.少なくとも部分工程として、請求項2から4のいずれか1項に記載の方法を 包含する、光学的活性の化合物の製法。 6.1級又は2級のヘテロ原子置換アミンとして、一般式I: [式中、nは、0、1、2、3であり;Yは、0、S、NH、NR5を表し; R1、R2は、相互に無関係に、それぞれH、アルキル又はアリールを表すか、 又はR1とR2もしくはR2とR3もしくはR1とR4は、隣接C−原子と一緒になっ て環系の一部をなし;R4はアルキル又はアリールアルキルを表し;R3、R5は 相互に無関係に、H、アルキル又はアリールアルキルを表す]のアミンを使用す る、請求項2又は3に記載の方法。 7.式中のYがOである式Iの化合物を使用する、請求項6に記載の方法。 8.式中のR4がメチル又はベンジルである、請求項7に記載の方法。 9.微生物学的リパーゼを使用する、請求項1から8のいずれか1項に記載の方 法。 10.エステルとしてメトキシ酢酸アルキルエステルを使用する、請求項1から9 のいずれか1項に記載の方法。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19503605.0 | 1995-02-03 | ||
| DE19503605 | 1995-02-03 | ||
| DE19523151A DE19523151A1 (de) | 1995-02-03 | 1995-06-29 | Racematspaltung primärer und sekundärer heteroatomsubstituierter Amine durch Enzym-katalysierte Acylierung |
| DE19523151.1 | 1995-06-29 | ||
| PCT/EP1996/000234 WO1996023894A1 (de) | 1995-02-03 | 1996-01-20 | Racematspaltung primärer und sekundärer heteroatomsubstituierter amine durch enzym-katalysierte acylierung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10512759A true JPH10512759A (ja) | 1998-12-08 |
| JP3789938B2 JP3789938B2 (ja) | 2006-06-28 |
Family
ID=26012141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52320596A Expired - Lifetime JP3789938B2 (ja) | 1995-02-03 | 1996-01-20 | 酵素触媒作用アシル化による1級及び2級のヘテロ原子置換アミンのラセミ体分割 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6214608B1 (ja) |
| EP (1) | EP0801683B1 (ja) |
| JP (1) | JP3789938B2 (ja) |
| CN (1) | CN1087348C (ja) |
| AT (1) | ATE217024T1 (ja) |
| DK (1) | DK0801683T3 (ja) |
| ES (1) | ES2176429T3 (ja) |
| PT (1) | PT801683E (ja) |
| WO (1) | WO1996023894A1 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003514888A (ja) * | 1999-11-25 | 2003-04-22 | ビーエーエスエフ アクチェンゲゼルシャフト | 光学活性アミンの製造方法 |
| JP2008546381A (ja) * | 2005-06-20 | 2008-12-25 | ビーエーエスエフ ソシエタス・ヨーロピア | 光学活性アミノアルキルフェノールの製造方法 |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3714964B2 (ja) * | 1995-12-06 | 2005-11-09 | バイエル・アクチエンゲゼルシヤフト | 光学活性アミン類の製造方法 |
| DE19727517A1 (de) * | 1997-06-30 | 1999-01-07 | Basf Ag | Racematspaltung von Aminosäureestern durch Enzym-katalysierte Acylierung |
| SK285908B6 (sk) | 1998-04-01 | 2007-10-04 | Nortran Pharmaceuticals Inc. | Aminocyklohexyléterová zlúčenina, kompozícia obsahujúca túto zlúčeninu, použitie tejto zlúčeniny pri výrobe liečiva a pri liečbe |
| DE19837745A1 (de) * | 1998-08-20 | 2000-02-24 | Basf Ag | Enzymkatalysierte Racematspaltung von primären Aminen |
| WO2000047547A2 (en) * | 1999-02-12 | 2000-08-17 | Nortran Pharmaceuticals Inc. | Cycloalkyl amine compounds and uses thereof |
| US6979685B1 (en) | 1999-02-12 | 2005-12-27 | Cardiome Pharma Corp. | Cycloalkyl amine compounds and uses thereof |
| US7507545B2 (en) | 1999-03-31 | 2009-03-24 | Cardiome Pharma Corp. | Ion channel modulating activity method |
| US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| US7524879B2 (en) | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
| US7067291B2 (en) * | 2002-12-20 | 2006-06-27 | Pfizer Inc. | Biocatalytic preparation of enantiomerically enriched aminopentanenitrile |
| US7345086B2 (en) | 2003-05-02 | 2008-03-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
| ES2264776T3 (es) | 2003-05-02 | 2007-01-16 | Cardiome Pharma Corp. | Compuestos de aminociclohexil eter y sus usos. |
| WO2005018635A2 (en) | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
| US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
| US7754897B2 (en) | 2005-06-15 | 2010-07-13 | Cardiome Pharma Corp. | Synthetic processes for the preparation of aminocyclohexyl ether compounds |
| US7705036B2 (en) | 2004-04-01 | 2010-04-27 | Cardiome Pharma Corp. | Deuterated aminocyclohexyl ether compounds and processes for preparing same |
| US8058304B2 (en) | 2004-04-01 | 2011-11-15 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
| WO2005113011A2 (en) | 2004-04-01 | 2005-12-01 | Cardiome Pharma Corp. | Prodrugs of ion channel modulating compounds and uses thereof |
| US8263638B2 (en) | 2004-11-08 | 2012-09-11 | Cardiome Pharma Corp. | Dosing regimens for ion channel modulating compounds |
| EP1828099B1 (en) | 2004-11-18 | 2020-01-22 | Correvio International Sàrl | Synthetic process for aminocyclohexyl ether compounds |
| ITMI20051943A1 (it) * | 2005-10-14 | 2007-04-15 | Procos Spa | Processo di risoluzione anantiomerica di 2-aminometil-pirrolidine 1-sostitute per ammidazione in presenza di lipasi |
| SI2069517T1 (sl) * | 2006-09-13 | 2011-05-31 | Basf Se | Postopek za proizvodnjo optiäśno aktivnega 2-benziloksicikloheksilamina |
| DK2387556T3 (da) * | 2009-01-16 | 2014-11-03 | Basf Se | Separation af en enantiomerblanding af (r)- og (s)-3-amino-1-butanol |
| US20130345475A1 (en) | 2012-06-25 | 2013-12-26 | Basf Se | Process for the racemization of optically active arylalkylamines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1191638B (it) * | 1985-10-31 | 1988-03-23 | Montedison Spa | Processo per la separazione enzimatica degli isomeri ottici del 2-amminobutanolo |
| US5057607A (en) | 1990-06-08 | 1991-10-15 | Eli Lilly And Company | Enantiomerically selective biocatalyzed acylation |
| JP3409353B2 (ja) * | 1992-04-30 | 2003-05-26 | 住友化学工業株式会社 | アミド化合物の製造方法および使用される微生物 |
| DE4332738A1 (de) * | 1993-09-25 | 1995-03-30 | Basf Ag | Racematspaltung primärer und sekundärer Amine durch Enzym-katalysierte Acylierung |
| US5512454A (en) * | 1994-02-03 | 1996-04-30 | Bristol-Myers Squibb Company | Enzymatic acylation of 3-hydroxymethyl cephalosporins |
-
1996
- 1996-01-20 PT PT96900601T patent/PT801683E/pt unknown
- 1996-01-20 JP JP52320596A patent/JP3789938B2/ja not_active Expired - Lifetime
- 1996-01-20 CN CN96191757A patent/CN1087348C/zh not_active Expired - Lifetime
- 1996-01-20 US US08/875,417 patent/US6214608B1/en not_active Expired - Lifetime
- 1996-01-20 WO PCT/EP1996/000234 patent/WO1996023894A1/de not_active Ceased
- 1996-01-20 DK DK96900601T patent/DK0801683T3/da active
- 1996-01-20 ES ES96900601T patent/ES2176429T3/es not_active Expired - Lifetime
- 1996-01-20 AT AT96900601T patent/ATE217024T1/de active
- 1996-01-20 EP EP96900601A patent/EP0801683B1/de not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003514888A (ja) * | 1999-11-25 | 2003-04-22 | ビーエーエスエフ アクチェンゲゼルシャフト | 光学活性アミンの製造方法 |
| JP2008546381A (ja) * | 2005-06-20 | 2008-12-25 | ビーエーエスエフ ソシエタス・ヨーロピア | 光学活性アミノアルキルフェノールの製造方法 |
| US7968328B2 (en) | 2005-06-20 | 2011-06-28 | Basf Se | Method for producing optically active aminoalkylphenols |
Also Published As
| Publication number | Publication date |
|---|---|
| DK0801683T3 (da) | 2002-06-17 |
| JP3789938B2 (ja) | 2006-06-28 |
| CN1087348C (zh) | 2002-07-10 |
| EP0801683B1 (de) | 2002-05-02 |
| ES2176429T3 (es) | 2002-12-01 |
| US6214608B1 (en) | 2001-04-10 |
| ATE217024T1 (de) | 2002-05-15 |
| PT801683E (pt) | 2002-09-30 |
| CN1172504A (zh) | 1998-02-04 |
| EP0801683A1 (de) | 1997-10-22 |
| WO1996023894A1 (de) | 1996-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3789938B2 (ja) | 酵素触媒作用アシル化による1級及び2級のヘテロ原子置換アミンのラセミ体分割 | |
| JP3594602B2 (ja) | 酵素触媒作用アシル化による1級及び2級アミンのラセミ分割 | |
| JP3010497B2 (ja) | 光学活性α―ヒドロキシエステル類の製造方法 | |
| CN1215434A (zh) | 立体选择性的制备治疗酰胺的酶催化方法 | |
| JP2006510364A (ja) | (r)または(s)体のn−(2,6−ジメチルフェニル)アラニンおよびその逆対掌体であるn−(2,6−ジメチルフェニル)アラニンエステルを、酵素を用いて調製する方法 | |
| JP4129077B2 (ja) | アシル化されたアミノ酸エステルおよび光学活性アミノ酸エステルの製造法、ならびに光学活性アミノ酸エステルおよびn−アシルアミノ酸エステル | |
| US6753443B1 (en) | Preparing method of chiral ester | |
| JP3565868B2 (ja) | 鏡像異性体的に濃縮したn−誘導体形成ラクタムの製造法 | |
| JP4843813B2 (ja) | 酵素を用いるR−体又はS−体のα−置換ヘテロサイクリックカルボン酸及びこれと反対鏡像の鏡像異性体のα−置換ヘテロサイクリックカルボン酸エステルの調製方法 | |
| US7156731B2 (en) | Resolution of chiral compounds using aminocyclopentadienyl ruthenium catalysts | |
| KR100419595B1 (ko) | 효소촉매된아실화반응에의한헤테로원자치환된1급및2급아민라세미체의분리방법 | |
| JP4843812B2 (ja) | 酵素を使用するラセミα−置換ヘテロ環式カルボン酸の光学分割方法 | |
| US20070077632A1 (en) | Method for preparing (s)-indoline-2-carboxylic acid and (s)-indoline-2-carboxylic acid methyl ester using hydrolytic enzyme | |
| CN1484631A (zh) | 对映体纯的羟基酯和酸的制备 | |
| JP5329973B2 (ja) | リパーゼ触媒を用いるエナンチオ選択的アシル化とその後の硫酸による沈殿によって、ラセミ体の4−(1−アミノエチル)安息香酸メチルエステルから(r)−および(s)−4−(1−アンモニウムエチル)安息香酸メチルエステル硫酸塩を調製する方法 | |
| US6475773B2 (en) | Method for preparing chiral esters | |
| CN101321875B (zh) | 从外消旋4-(1-氨基乙基)苯甲酸甲酯通过脂酶催化的对映选择性酰化反应并随后用硫酸沉淀以制备(r)-和(s)-4-(1-铵乙基)苯甲酸甲酯硫酸盐的方法 | |
| JPH1175889A (ja) | 光学活性α−トリフルオロメチル乳酸及びその対掌体エステルの製造方法及び精製方法 | |
| EP1536017B1 (en) | Process for producing optically active octahydro-1H-indole-2-carboxylic acid | |
| CA2210519C (en) | Resolution of racemates of primary and secondary heteroatom-substituted amines by enzyme-catalyzed acylation | |
| US7326559B2 (en) | Process for preparation of optically active allenes | |
| EP1650187A1 (en) | Optically active 2-allylcarboxylic acid derivative and process for producing the same | |
| WO2006009338A1 (en) | Process for preparing chiral substituted carboxylic acid | |
| HK1019619A (en) | Enzymatic process for stereoselective preparation of therapeutic amides | |
| FR2700537A1 (fr) | 1-Hydroxy-2-alcoxycarbonyl-tétralines optiquement pures, procédé pour leur préparation et leur utilisation comme intermédiaires clés de synthèse. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040301 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040323 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040618 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040802 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040909 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050517 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050815 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20050901 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051007 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060110 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060301 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060330 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090407 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100407 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110407 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120407 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130407 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140407 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |